Immunogenicity and Safety of Extended Dosing Intervals for Pfizer Pentavalent MenABCWY Meningococcal Vaccination in Healthy Adolescents: Results from a Randomized, Phase 2b Study.
Saved in:
| Title: | Immunogenicity and Safety of Extended Dosing Intervals for Pfizer Pentavalent MenABCWY Meningococcal Vaccination in Healthy Adolescents: Results from a Randomized, Phase 2b Study. |
|---|---|
| Authors: | Jones JC; Wasatch Pediatrics, Murray, UT 84107, USA., Tipton MD; CopperView Medical Center, South Jordan, UT 84095, USA., Zolotas L; Pfizer Vaccine Research and Development, Marlow SL7 1YL, UK., Maguire JD; Pfizer Vaccine Research and Development, Collegeville, PA 19426, USA., Belanger K; Pfizer Vaccine Research and Development, Pearl River, NY 10965, USA., Liu Y; Pfizer Vaccine Research and Development, Collegeville, PA 19426, USA., Maansson R; Pfizer Vaccine Research and Development, Collegeville, PA 19426, USA., O'Neill RE; Pfizer Vaccine Research and Development, Pearl River, NY 10965, USA., Balmer P; Pfizer US Vaccines Medical Affairs, Collegeville, PA 19426, USA., Peyrani P; Pfizer US Vaccines Medical Affairs, Collegeville, PA 19426, USA., Beeslaar J; Pfizer Vaccine Research and Development, Marlow SL7 1YL, UK. |
| Source: | Vaccines [Vaccines (Basel)] 2026 Apr 15; Vol. 14 (4). Date of Electronic Publication: 2026 Apr 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42042828 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity and Safety of Extended Dosing Intervals for Pfizer Pentavalent MenABCWY Meningococcal Vaccination in Healthy Adolescents: Results from a Randomized, Phase 2b Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jones+JC%22">Jones JC</searchLink>; Wasatch Pediatrics, Murray, UT 84107, USA.<br /><searchLink fieldCode="AU" term="%22Tipton+MD%22">Tipton MD</searchLink>; CopperView Medical Center, South Jordan, UT 84095, USA.<br /><searchLink fieldCode="AU" term="%22Zolotas+L%22">Zolotas L</searchLink>; Pfizer Vaccine Research and Development, Marlow SL7 1YL, UK.<br /><searchLink fieldCode="AU" term="%22Maguire+JD%22">Maguire JD</searchLink>; Pfizer Vaccine Research and Development, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Belanger+K%22">Belanger K</searchLink>; Pfizer Vaccine Research and Development, Pearl River, NY 10965, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Pfizer Vaccine Research and Development, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Maansson+R%22">Maansson R</searchLink>; Pfizer Vaccine Research and Development, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22O'Neill+RE%22">O'Neill RE</searchLink>; Pfizer Vaccine Research and Development, Pearl River, NY 10965, USA.<br /><searchLink fieldCode="AU" term="%22Balmer+P%22">Balmer P</searchLink>; Pfizer US Vaccines Medical Affairs, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Peyrani+P%22">Peyrani P</searchLink>; Pfizer US Vaccines Medical Affairs, Collegeville, PA 19426, USA.<br /><searchLink fieldCode="AU" term="%22Beeslaar+J%22">Beeslaar J</searchLink>; Pfizer Vaccine Research and Development, Marlow SL7 1YL, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101629355%22">Vaccines</searchLink> [Vaccines (Basel)] 2026 Apr 15; Vol. 14 (4). <i>Date of Electronic Publication: </i>2026 Apr 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI+AG%22">MDPI AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101629355 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2076-393X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222076393X%22">2076393X </searchLink><i>NLM ISO Abbreviation: </i>Vaccines (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42042828 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/vaccines14040352 Languages: – Code: eng Text: English Titles: – TitleFull: Immunogenicity and Safety of Extended Dosing Intervals for Pfizer Pentavalent MenABCWY Meningococcal Vaccination in Healthy Adolescents: Results from a Randomized, Phase 2b Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jones JC – PersonEntity: Name: NameFull: Tipton MD – PersonEntity: Name: NameFull: Zolotas L – PersonEntity: Name: NameFull: Maguire JD – PersonEntity: Name: NameFull: Belanger K – PersonEntity: Name: NameFull: Liu Y – PersonEntity: Name: NameFull: Maansson R – PersonEntity: Name: NameFull: O'Neill RE – PersonEntity: Name: NameFull: Balmer P – PersonEntity: Name: NameFull: Peyrani P – PersonEntity: Name: NameFull: Beeslaar J IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 04 Text: 2026 Apr 15 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2076-393X Numbering: – Type: volume Value: 14 – Type: issue Value: 4 Titles: – TitleFull: Vaccines Type: main |
| ResultId | 1 |
